Risk for major osteoporotic fractures up for insulin versus metformin for those with HbA1c <7 percent, BMI <25 kg/m2
Read More »ENDO: Disparities Seen in Access to Insulin Pumps for Youth With T1D
Likelihood of insulin pump use for T1D increased for Hispanic youth, but not for youth of Black and other races compared to non-Hispanic Whites
Read More »ENDO: Guidelines Updated for Hospitalized Adults With Hyperglycemia
Guidelines address glycemic management in noncritically ill hospitalized adults with diabetes or newly recognized hyperglycemia
Read More »ENDO: Fezolinetant Cuts Vasomotor Symptoms in Menopause
Frequency and severity of vasomotor symptoms reduced with fezolinetant versus placebo through 12 weeks
Read More »Testosterone Therapy for Hypogonadism Not Tied to Increased CV Risk
No evidence of increase seen for short- to medium-term cardiovascular risk, but data lacking regarding long-term safety
Read More »Women With PCOS Report More Morbidity, Medication Use
Prevalence increased for self-reported diagnoses of migraine, hypertension, tendinitis, osteoarthritis, and endometriosis
Read More »ADA: Diabetes May Quadruple Risk for Long COVID
Authors say review findings are limited by heterogenous definitions of long COVID in published studies
Read More »ADA: Once-Weekly Dulaglutide Ups Glycemic Control in Youth With T2D
Mean glycated hemoglobin level at 26 weeks increased with placebo, decreased with dulaglutide among youth with BMI >85th percentile
Read More »ADA: Elevated BMI in Adolescence Linked to T1D in Young Adulthood
Risk for incidence of type 1 diabetes increased 25 percent in association with one increment in BMI standard deviation
Read More »Metformin Does Not Improve Survival in High-Risk Breast Cancer
Incidence rate of invasive disease-free survival events and incidence rates for death did not differ with addition of metformin, placebo
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.